News Chart Galmed Pharmaceuticals Ltd.

Equities

GLMD

IL0011313900

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-13 pm EDT			5-day change	1st Jan Change
0.3883 ^USD	-2.51%		-7.37%	-14.66%

Apr. 04	Galmed Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 15	Galmed Pharmaceuticals Ltd. Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of Nash and Liver Fibrosis	CI

204d3500e0f816bbe304926cf.mIpIL9-NeESbSgg6tP2MjhpfTImtv7uCYQKB9XuPUsI._e8pVejVTi_WOlt87JChwmxtGrzs1dnDInrJww_4E4z78g5pkcUcHfASbw~bb925be91eae4380ae8f7230355eeb2c